Opendata, web and dolomites


Biomimetic nano-coatings for healthcare. Targeting the contact lenses market

Total Cost €


EC-Contrib. €






 LIPOCOAT project word cloud

Explore the words cloud of the LIPOCOAT project. It provides you a very rough idea of what is the project "LIPOCOAT" about.

view    efficiency    biofouling    projected    opportunity    2020    prevent    32    close    business    lipid    water    billion    time    deposits    interaction       medical    outside    sales    cls    flow    national    first    bio    natural    launching    extremely    fluids    cell    molecules    decided    11    proprietary    biomolecules    lipocoat    bodily    biomedical    market    performance    nano    vitro    attract    global    cumulative    commercialization    95    preventing    investment    biocompatible    ties    million    neutral    roi    demonstrated    international    coatings    layers    cells    2019    vivo    bacteria    lenses    found    manufacturers    contact    stably    forecast    proteins    placed    body    bacterial    cagr    bilayers    recovered    comfort    patented    wetting    10    manufacturing    demo    fifth    surface    benefits    industrialization    device    initial    cash    fast    16    improvement    adhesion    2014    clear    lubricity    coating    inspired    commercial    estimates   

Project "LIPOCOAT" data sheet

The following table provides information about the project.


Organization address
postcode: 7522 NB
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-03-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIPOCOAT BV NL (ENSCHEDE) coordinator 50˙000.00


 Project objective

Biofouling, i.e. the formation of deposits of biomolecules or even bacteria in the surface of the medical device, is the main cause of the loss of the devices performance. LipoCoat’s patented nano-coatings make use of lipid bilayers to prevent biofouling of medical devices when placed into contact with bodily fluids in- or outside of the body. Our natural and bio-inspired coating makes use of molecules found in every cell, making it extremely biocompatible. The neutral LipoCoat molecules can efficiently attract water thus preventing any interaction with proteins and cells. Furthermore, LipoCoat can stably apply these layers using our proprietary LipoCoat FAST manufacturing process. Among the wide range of biomedical applications for LipoCoat nano-coatings, we decided to target the contact lenses as it presents a clear business opportunity (a € 11.4 billion global market with a projected CAGR of 7-10% 2014-2019). Demo studies, both in vitro and in vivo, have demonstrated the LipoCoat coating efficiency and its benefits on contact lenses: 95% reduction in bacterial adhesion, improved wetting and lubricity and comfort improvement. In view of these promising results, we were able to establish close ties with leading national and international CLs manufacturers.

The next step for LipoCoat’s commercial success on the contact lenses market, which comprises the main objective of this project, is the industrialization of our proprietary manufacturing process to scale-up the production of LipoCoat nano-coatings. We expect a time-to-market of 2 years, launching our product on the CLs market by 2020. Our initial sales forecast estimates a cumulative cash flow of € 32.2 million after the five first years of commercialization. The estimated investment needed, € 2 million, will be recovered after only two years, and the estimated ROI after the fifth commercialization year is 16.2%.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIPOCOAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIPOCOAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)


Super Productive Line Printing Inkjet

Read More  

HelpingHAND (2018)

A 3D printed, affordable myoelectrical prosthetic hand of personalizeable size for optimal comfort and functionality

Read More  

Volumizer (2018)

A natural, non-surgical, and safe facial filler which treats the root cause of facial ageing.

Read More